Skip to main content
SpringerLink
Log in

Viral Hepatitis

  • Chapter
  • First Online:
Refugee Health Care

  • 1734 Accesses

Abstract

Refugees have been born in, or have lived in, regions highly endemic for the various viral hepatitides compared to the developed countries where they relocate. National guidelines for medical screening and vaccination, including guidelines for viral hepatitis in newly arrived refugees to the United States are developed by the Center for Disease Control and Prevention’s Division of Global Migration and Quarantine (CDC/DGMQ) and issued by the Office of Refugee Resettlement (ORR) Domestic Medical Screening Guidelines Checklist. Routine screening for Hepatitis B is recommended for all refugees. While Hepatitis C screening is not routinely recommended, the cost benefit of screening refugees from high prevalence countries is suggested. Screening for Hepatitis A and E is not needed for newly arrived refugees. This chapter reviews these screening guidelines as well as characteristics of the different viral hepatitides, serology testing, and vaccination recommendations for refugees.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. World Health Organization position paper on hepatitis B vaccines. Weekly Epidemiological Record, No. 40, 2009;84:405–20.

    Google Scholar 

  2. Greenaway C, Wong DKH, Assayag D, et al. Screening for hepatitis C infection: evidence review for arriving immigrants and refugees. Appendix 7. Guidelines for immigrant health. CMAJ. 2011. doi:10.1503/cmaj.090313.

    Google Scholar 

  3. Weinbaum CM, Williams I, Mast EE, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Morb Mortal Wkly Rep. 2008;57(RR-8):1–20.

    Google Scholar 

  4. Center for Disease Control and Prevention. Evaluating and updating immunizations during the domestic medical examination for newly arrived refugees. Immigrant and refugee health domestic guidelines. 2012 [last updated 2012 Sep 27]. Available at: http://www.cdc.gov/immigrantrefugeehealth/guidelines/domestic/immunizations-guidelines.html. Accessed 3 May 2013.

  5. Office of Refugee Resettlement. Medical screening protocol for newly arriving refugees. ORR’s Domestic medical screening guidelines checklist attached to state letter 12-09 (07/24/12). Available at: http://www.acf.hhs.gov/programs/orr/resource/medical-screening-protocol-for-newly-arriving-refugees. Accessed 2 May 2013.

  6. Association of Refugee Health Coordinators Medical Screening Committee Tools and Recommendations. Available at: http://www.astho.org/Programs/Infectious-Disease/Refugee-Health/ARHC-Medical-Screening-Recommendations/. Accessed 3 May 2013.

  7. Beasley RP, Hwang LY. Overview of the epidemiology of hepatocellular carcinoma. In: Hollinger FB, Lemon SM, Margolis HS, editors. Viral hepatitis and liver disease. Proceedings of the 1990 International Symposium on Viral Hepatitis and Liver Disease: contemporary issues and future prospects. Baltimore, MD: Williams & Wilkins; 1991. p. 532–5.

    Google Scholar 

  8. Goldstein ST, Zhou F, Hadler SC, et al. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol. 2005;34:1329–39.

    Article  PubMed  Google Scholar 

  9. Perz JF, Armstrong GL, Farrington LA, et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.

    Article  PubMed  Google Scholar 

  10. Rein DB, Lesesne SB, O’Fallon A, et al. Prevalence of hepatitis B surface antigen among refugees entering the United States between 2006 and 2008. Hepatology. 2009;51:431–4.

    Article  Google Scholar 

  11. Kowdley KV, Wang CC, Welch S, et al. Prevalence of chronic hepatitis B among foreign-born persons living in the United States by country of origin. Hepatology. 2012;56:422–33. doi:10.1002/hep.24804.

    Article  PubMed  Google Scholar 

  12. Kim WR, Terrault NA, Pedersen RA, et al. Trends in waitlist registration for liver transplantation for viral hepatitis in the US. Gastroenterology. 2009;137:1680–6.

    Article  PubMed Central  PubMed  Google Scholar 

  13. Institute of Medicine. Hepatitis and liver cancer: a national strategy for prevention and control of hepatitis B and C. Washington, DC: The National Academies Press; 2010.

    Google Scholar 

  14. Cohen C, Holmberg SD, McMahon BJ, et al. Is chronic hepatitis B being undertreated in the United States? J Viral Hepat. 2011;18:377–83.

    Article  CAS  PubMed  Google Scholar 

  15. Keystone JS. Chapter 58 Visiting friends and relatives. In: Walker PF, Barnett ED, editors. Immigrant medicine. Philadelphia, PA: Saunders Elsevier; 2007. p. 747.

    Google Scholar 

  16. Mast EE, Margolis HS, Fiore AE, Brink EW, Goldstein ST, Wang SA, Moyer LA, Bell BP, Alter MJ, Advisory Committee on Immunization Practices (ACIP). A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the advisory committee on immunization practices. Part I: Immunization of infants, children, and adolescents. MMWR Morb Mortal Wkly Rep. 2005;54(RR-16):1–31.

    Google Scholar 

  17. World Health Organization. Hepatitis Delta. Geneva: World Health Organization; 2001. Available at: http://www.who.int/csr/disease/hepatitis/HepatitisD_whocdscsrncs2001_1.pdf. Accessed 3 May 2013.

  18. Rizzeto M, Ponzetto A, Forzani I. Epidemiology of hepatitis delta virus: overview. Prog Clin Biol Res. 1991;364:1–20.

    Google Scholar 

  19. Chironna M, Germinario C, Lopalco PL, et al. HBV, HCV and HDV infections in Albanian refugees in Southern Italy (Apulia region). Epidemiol Infect. 2000;125(1):163–7.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  20. Maynard JE, Hadler SC, Fields HA. Delta hepatitis in the Americas: an overview. Prog Clin Biol Res. 1987;234:493–505.

    CAS  PubMed  Google Scholar 

  21. World Health Organization Hepatitis C fact sheet 2011. Available at: http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed 2 May 2013.

  22. World Health Organization. Hepatitis C—global prevalence (update). Wkly Epidemiol Rec. 1999;74:425–7.

    Google Scholar 

  23. Global Burden of Hepatitis C Working Group. Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol. 2004;44(1):20–9.

    Article  Google Scholar 

  24. CDC. Progress toward prevention and control of hepatitis C virus infection—Egypt, 2001–2012. MMWR Morb Mortal Wkly Rep. 2012;61(29):545–9.

    Google Scholar 

  25. Syed AA, Donahue RMJ, Qureshi H, et al. Hepatitis B and hepatitis C in Pakistan: prevalence and risk factors. Int J Infect Dis. 2009;13(1):9–19.

    Article  Google Scholar 

  26. Centers for Disease Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep. 1998;47(RR-19):1–39.

    Google Scholar 

  27. Ghany MG, Strader DB, Thomas DL, et al. Diagnosis, management, and treatment of hepatitis C: an update. Hepatology. 2009;49:1335–74.

    Article  CAS  PubMed  Google Scholar 

  28. Kamal SM, Rasenack JW, Bianchi L, et al. Acute hepatitis C without and with schistosomiasis: correlation with hepatitis C-specific CD4+ T-cell and cytokine response. Gastroenterology. 2001;121(3):646–56.

    Article  CAS  PubMed  Google Scholar 

  29. Koshy A, al-Nakib B, al-Mufti S, et al. Anti-HCV-positive cirrhosis associated with schistosomiasis. Am J Gastroenterol. 1993;88(9):1428–31.

    CAS  PubMed  Google Scholar 

  30. Centers for Disease Control and Prevention. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR Morb Mortal Wkly Rep. 2012;61(RR-4):1–32.

    Google Scholar 

  31. WHO position paper on hepatitis A vaccines. Weekly epidemiological record No. 28–29, 2012;87:261–76.

    Google Scholar 

  32. Centers for Disease Control and Prevention. Chapter 8 Hepatitis A epidemiology and prevention of vaccine-preventable diseases. In: Atkinson W, Wolfe S, Hamborsky J, editors. The pink book—epidemiology & prevention of vaccine-preventable diseases. 12th ed. Washington, DC: Public Health Foundation; 2012. second printing.

    Google Scholar 

  33. Jacobsen KH, Wiersma ST. Hepatitis A virus seroprevalence by age and world region, 1990 and 2005. Vaccine. 2010;28(41):6653–7.

    Article  PubMed  Google Scholar 

  34. CDC. Prevention of hepatitis A through active or passive immunization. Recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2006;55(RR-7):1–23.

    Google Scholar 

  35. Bryan JP, Nelson M. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Arch Intern Med. 1994;154: 663–8.

    Article  CAS  PubMed  Google Scholar 

  36. Center for Disease Control and Prevention Division of Viral Hepatitis. Hepatitis E information for health professionals. Overview and statistics. Available at: http://www.cdc.gov/hepatitis/HEV/HEVfaq.htm. Accessed 3 May 2013.

  37. Previsani N, Lavanchy D. Hepatitis E. World Health Organization Department of Communicable Disease Surveillance and Response WHO/CDS/CSR/EDC/2001.12. http://www.who.int/csr/disease/hepatitis/HepatitisA_whocdscsredc2000_7.pdf

  38. Navaneethan U, Al Mohajer M, Shata MT. Hepatitis E and pregnancy: understanding the pathogenesis. Liver Int. 2008;28:1190–9. doi:10.1111/j.1478-3231.2008.01840.x.

    Article  PubMed Central  PubMed  Google Scholar 

  39. Dalton HR, Bendall RP, Keane FE, et al. Persistent carriage of Hepatitis E in patients with HIV infection. N Engl J Med. 2009;361:1025–7.

    Article  CAS  PubMed  Google Scholar 

  40. Kamar N, Selves J, Mansuy JM, et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med. 2008;358(8):811–7.

    Article  CAS  PubMed  Google Scholar 

  41. Center for Disease Control and Prevention Division of Viral Hepatitis. Hepatitis E Information for Health Professionals. 2012 [last updated 2012 Sep 14]. Available at: http://www.cdc.gov/hepatitis/HEV/LabTestingRequests.htm. Accessed 2 May 2013.

Download references

Author information

Authors and Affiliations

  1. General Internal Medicine, Hennepin Country Medical Center, University of Minnesota, 701 Park Avenue S, Minneapolis, MN, 55415, USA

    Douglas J. Pryce M.D. & Asha M. J. Madhar M.D.

Authors
  1. Douglas J. Pryce M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Asha M. J. Madhar M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Douglas J. Pryce M.D. .

Editor information

Editors and Affiliations

  1. Depts. of Internal Medicine & Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA

    Aniyizhai Annamalai

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this chapter

Cite this chapter

Pryce, D.J., Madhar, A.M.J. (2014). Viral Hepatitis. In: Annamalai, A. (eds) Refugee Health Care. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-0271-2_7

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-0271-2_7

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-0270-5

  • Online ISBN: 978-1-4939-0271-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation